Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 50

    1.

    Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2.

    Umbach JL, Wang K, Tang S, Krause PR, Mont EK, Cohen JI, Cullen BR.

    J Virol. 2009 Nov 4. [Epub ahead of print]PMID: 19889786 [PubMed - as supplied by publisher]Related articles

    2.

    An annual vaccine: seasonal influenza.

    Jivapaisarnpong T, Krause PR.

    Biologicals. 2009 Nov;37(6):410-1; discussion 421-3. Epub 2009 Oct 21.PMID: 19850497 [PubMed - in process]Related articles

    3.

    A vaccine measured with a highly variable assay: rabies.

    Jivapaisarnpong T, Schofield T, Krause PR.

    Biologicals. 2009 Nov;37(6):412-5; discussion 421-3. Epub 2009 Oct 20.PMID: 19846319 [PubMed - in process]Related articles

    4.

    Stability evaluation of vaccines.

    Schofield T, Krause PR.

    Biologicals. 2009 Nov;37(6):355. Epub 2009 Sep 26. No abstract available. PMID: 19783158 [PubMed - in process]Related articles

    5.

    Goals of stability evaluation throughout the vaccine life cycle.

    Krause PR.

    Biologicals. 2009 Nov;37(6):369-78; discussion 421-3. Epub 2009 Sep 22.PMID: 19775911 [PubMed - in process]Related articles

    6.

    Latency-associated transcript (LAT) exon 1 controls herpes simplex virus species-specific phenotypes: reactivation in the guinea pig genital model and neuron subtype-specific latent expression of LAT.

    Bertke AS, Patel A, Imai Y, Apakupakul K, Margolis TP, Krause PR.

    J Virol. 2009 Oct;83(19):10007-15. Epub 2009 Jul 29.PMID: 19641003 [PubMed - indexed for MEDLINE]Related articles

    7.

    Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia.

    Imai Y, Apakupakul K, Krause PR, Halford WP, Margolis TP.

    J Virol. 2009 Aug;83(16):7873-82. Epub 2009 Jun 3.PMID: 19493993 [PubMed - indexed for MEDLINE]Related articles

    8.

    Use of a universal virus detection assay to identify human metapneumovirus in a hematopoietic stem cell transplant recipient with pneumonia of unknown origin.

    Uhlenhaut C, Cohen JI, Fedorko D, Nanda S, Krause PR.

    J Clin Virol. 2009 Apr;44(4):337-9. Epub 2009 Feb 27.PMID: 19250860 [PubMed - indexed for MEDLINE]Related articles

    9.

    Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs.

    Tang S, Patel A, Krause PR.

    J Virol. 2009 Feb;83(3):1433-42. Epub 2008 Nov 19.PMID: 19019961 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor.

    Tang S, Bertke AS, Patel A, Wang K, Cohen JI, Krause PR.

    Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10931-6. Epub 2008 Aug 4.PMID: 18678906 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Universal virus detection by degenerate-oligonucleotide primed polymerase chain reaction of purified viral nucleic acids.

    Nanda S, Jayan G, Voulgaropoulou F, Sierra-Honigmann AM, Uhlenhaut C, McWatters BJ, Patel A, Krause PR.

    J Virol Methods. 2008 Sep;152(1-2):18-24. Epub 2008 Jul 16.PMID: 18601953 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pseudohyperphosphatemia associated with high-dose liposomal amphotericin B therapy.

    Lane JW, Rehak NN, Hortin GL, Zaoutis T, Krause PR, Walsh TJ.

    Clin Chim Acta. 2008 Jan;387(1-2):145-9. Epub 2007 Aug 30.PMID: 17936740 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism.

    Bertke AS, Patel A, Krause PR.

    J Virol. 2007 Jun;81(12):6605-13. Epub 2007 Apr 4.PMID: 17409161 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.

    Margolis TP, Imai Y, Yang L, Vallas V, Krause PR.

    J Virol. 2007 Feb;81(4):1872-8. Epub 2006 Dec 6.PMID: 17151134 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Development of herpes simplex virus disease in patients who are receiving cidofovir.

    Wyles DL, Patel A, Madinger N, Bessesen M, Krause PR, Weinberg A.

    Clin Infect Dis. 2005 Sep 1;41(5):676-80. Epub 2005 Jul 26.PMID: 16080090 [PubMed - indexed for MEDLINE]Related articles

    16.

    Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.

    Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR.

    J Infect Dis. 2003 Oct 1;188(7):954-9. Epub 2003 Sep 26.PMID: 14513413 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacoepidemiologic implications of erroneous varicella vaccinations in pregnancy through confusion with Varicella zoster immune globulin.

    Wise RP, Braun MM, Seward JF, Mootrey GT, Shields KE, Salive ME, Krause PR.

    Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):651-4.PMID: 12512240 [PubMed - indexed for MEDLINE]Related articles

    18.

    Live oral poliovirus vaccines and simian cytomegalovirus.

    Sierra-Honigmann AM, Krause PR.

    Biologicals. 2002 Sep;30(3):167-74.PMID: 12217341 [PubMed - indexed for MEDLINE]Related articles

    19.

    Conceptual and experimental approaches to address product safety issues raised by novel cell substrates.

    Krause PR.

    Dev Biol (Basel). 2001;106:45-8; discussion 49-50.PMID: 11761261 [PubMed - indexed for MEDLINE]Related articles

    20.

    Adventitious agents and vaccines.

    Krause PR.

    Emerg Infect Dis. 2001;7(3 Suppl):562. No abstract available. PMID: 11485673 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees.

    Krause PR.

    Arch Virol Suppl. 2001;(17):7-15.PMID: 11339552 [PubMed - indexed for MEDLINE]Related articles

    23.

    Disseminated rashes and varicella vaccine.

    Krause PR, Klinman DM.

    Pediatr Infect Dis J. 2001 Apr;20(4):467-8. No abstract available. PMID: 11332687 [PubMed - indexed for MEDLINE]Related articles

    24.

    Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes.

    Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS.

    J Clin Microbiol. 2000 Dec;38(12):4315-9.PMID: 11101557 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Reply to "Varicella vaccine revisited"

    Krause PR, Klinman DM.

    Nat Med. 2000 Dec;6(12):1300. No abstract available. PMID: 11100090 [PubMed - as supplied by publisher]Related articles

    26.

    Postlicensure safety surveillance for varicella vaccine.

    Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR.

    JAMA. 2000 Sep 13;284(10):1271-9. Erratum in: JAMA 2000 Dec 27;284(24):3129. PMID: 10979114 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.

    Loparev VN, Argaw T, Krause PR, Takayama M, Schmid DS.

    J Clin Microbiol. 2000 Sep;38(9):3156-60.PMID: 10970349 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Live oral poliovirus vaccines do not contain detectable simian virus 40 (SV40) DNA.

    Sierra-Honigmann A, Krause PR.

    Biologicals. 2000 Mar;28(1):1-4.PMID: 10799049 [PubMed - indexed for MEDLINE]Related articles

    29.

    Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.

    Krause PR, Klinman DM.

    Nat Med. 2000 Apr;6(4):451-4.PMID: 10742154 [PubMed - indexed for MEDLINE]Related articles

    30.

    Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.

    Argaw T, Cohen JI, Klutch M, Lekstrom K, Yoshikawa T, Asano Y, Krause PR.

    J Infect Dis. 2000 Mar;181(3):1153-7.PMID: 10720545 [PubMed - indexed for MEDLINE]Related articles

    31.

    Safety of viral DNA in biological products.

    Krause PR, Lewis AM Jr.

    Biologicals. 1998 Dec;26(4):317-20.PMID: 10403035 [PubMed - indexed for MEDLINE]Related articles

    32.

    Recent advances in varicella-zoster virus infection.

    Cohen JI, Brunell PA, Straus SE, Krause PR.

    Ann Intern Med. 1999 Jun 1;130(11):922-32. Review.PMID: 10375341 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Herpesvirus vaccines. Development, controversies, and applications.

    Krause PR, Straus SE.

    Infect Dis Clin North Am. 1999 Mar;13(1):61-81, vi. Review.PMID: 10198792 [PubMed - indexed for MEDLINE]Related articles

    34.

    Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides.

    Suzuki K, Mori A, Ishii KJ, Saito J, Singer DS, Klinman DM, Krause PR, Kohn LD.

    Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2285-90.PMID: 10051633 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice.

    Lekstrom-Himes JA, Wang K, Pesnicak L, Krause PR, Straus SE.

    J Neurovirol. 1998 Feb;4(1):27-37.PMID: 9531009 [PubMed - indexed for MEDLINE]Related articles

    36.

    The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region.

    Yoshikawa T, Hill JM, Stanberry LR, Bourne N, Kurawadwala JF, Krause PR.

    J Exp Med. 1996 Aug 1;184(2):659-64.PMID: 8760819 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine.

    Krause PR, Klinman DM.

    J Pediatr. 1995 Oct;127(4):518-25. Review. No abstract available. PMID: 7562270 [PubMed - indexed for MEDLINE]Related articles

    39.
    40.

    Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs.

    Krause PR, Stanberry LR, Bourne N, Connelly B, Kurawadwala JF, Patel A, Straus SE.

    J Exp Med. 1995 Jan 1;181(1):297-306.PMID: 7807009 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.

    Straus SE, Corey L, Burke RL, Savarese B, Barnum G, Krause PR, Kost RG, Meier JL, Sekulovich R, Adair SF, et al.

    Lancet. 1994 Jun 11;343(8911):1460-3.PMID: 7911177 [PubMed - indexed for MEDLINE]Related articles

    42.

    Quantity of latency-associated transcript produced by herpes simplex virus is not predictive of the frequency of experimental recurrent genital herpes.

    Bourne N, Stanberry LR, Connelly BL, Kurawadwala J, Straus SE, Krause PR.

    J Infect Dis. 1994 May;169(5):1084-7.PMID: 8169396 [PubMed - indexed for MEDLINE]Related articles

    43.

    A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.

    Goins WF, Sternberg LR, Croen KD, Krause PR, Hendricks RL, Fink DJ, Straus SE, Levine M, Glorioso JC.

    J Virol. 1994 Apr;68(4):2239-52.PMID: 8139009 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine.

    Straus SE, Savarese B, Tigges M, Freifeld AG, Krause PR, Margolis DM, Meier JL, Paar DP, Adair SF, Dina D, et al.

    J Infect Dis. 1993 May;167(5):1045-52.PMID: 8387560 [PubMed - indexed for MEDLINE]Related articles

    46.

    A review of algorithms for molecular sequence comparison.

    Tyler EC, Horton MR, Krause PR.

    Comput Biomed Res. 1991 Feb;24(1):72-96.PMID: 2004526 [PubMed - indexed for MEDLINE]Related articles

    47.

    Zoster and its complications.

    Krause PR, Straus SE.

    Hosp Pract (Off Ed). 1990 Oct 30;25(10A):61-71, 75-6. No abstract available. PMID: 2120265 [PubMed - indexed for MEDLINE]Related articles

    48.

    Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.

    Krause PR, Croen KD, Ostrove JM, Straus SE.

    J Clin Invest. 1990 Jul;86(1):235-41.PMID: 2365817 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Tendency to serious sequelae of infection with the human immunodeficiency virus in sibships with hemophilia.

    Meropol NJ, Krause PR, Ratnoff OD, Eyster ME, Levine PH, White GC, Debanne S, Rowland D, Lederman MM.

    Arch Intern Med. 1989 Apr;149(4):885-8.PMID: 2705837 [PubMed - indexed for MEDLINE]Related articles

    50.

    Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia.

    Krause PR, Croen KD, Straus SE, Ostrove JM.

    J Virol. 1988 Dec;62(12):4819-23.PMID: 2846893 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...